Delegration of United Front Work Department Came to Laipson to Guide Work

The Luo River bears its chapters, the Divine Capital gathers its momentum, and the Golden Ox ushers in prosperity; the livestock industry carries its mission, and united efforts open a new journey. On this fertile land of Luoyang, deeply rooted in the high-quality development of the cattle industry and the aggregation of synergistic industal forces, a grand industry summit focusing on cattle health protection and empowering the upgrade of epidemic prevention systems has officially opened. Industry luminaries and practitioners, including Han Li, Deputy Director n Provincial Institute of Inspection Technology for Agricultural, Livestock and Aquatic Products; Wang Shanpu, Chairman of Modern Biological Group; and Lang Hongwu, Director of Modern Biological Researh Institute, member of the Committee of the *Chinese Pharmacopoeia* for Veterinary Drugs under the Ministry of Agriculture and Rural Affairs, and Fellow of the Royal Academy of Engineering, h gathered in Luoyang to discuss cutting-edge trends in cattle epidemic prevention, deliberate on paths for industrial innovation and development, and jointly draw a new blueprint for the industry featuring cattle, livestock prosperity, and empowered win-win cooperation.

In accordance with the provisions of the Regulations on the Administration of Veterinary Drugs and the Measures for the Administration of Approval Numbers for Veterinary Drug Products, and upeview by the Ministry of Agriculture and Rural Affairs, Luoyang Worpson Biological Engineering Co., Ltd. is hereby approved to produce the Inactivated Vaccine against BoNodular Dermatitis (NMG Strain, Suspension Culture), and the approval number for the veterinary drug product is hereby issued.

Hiking activities can cultivate a spirit of unity and mutual assistance among team members, enhancing the team's cohesion and combat effectiveness. 2.Everyone actively participated in the company's team-building activities, demonstrating team spirit and mutual support, showcasing the company's positive image.

1.Chairman Wang Shanpu of Modern Biological Group made an annual summary and planned a new blueprint for development. In 2025, the deepened its focus on the life and health industry, worked hard to overcome difficulties, innovated and developed, solidified the foundation of research and development, and achieved a dual increase brand influence and team collaboration efficiency, successfully completing various business tasks. In 2026, the Group will take technological innovation as the core, unite as one, strive for, and work together to create a new situation of high-quality development.

According to the provisions of the Regulations on the Administration of Veterinary Drugs and the Measures for the Administration of Approval Numbers of Veterinary Drug Products, examination by the Ministry of Agriculture and Rural Affairs, the production of duck infectious bacteremia and colibacillosis bivalent inactivated vaccine (CZ12 strain 1 O78 strain SH) by Luoyang Worpson Biological Engineering Co., Ltd. is approved, and the approval number of veterinary drug products is.